Neurology Positioned To Benefit From Progress In Regenerative Therapies

[Guest guest]

Neurology Positioned To Benefit From Progress In Regenerative

Therapies

http://www.medicalnewstoday.com/medicalnews.php?newsid=47390

Diseases and injuries that affect central nervous system neurons are

among the illnesses that are hardest to cure. Their frequency

increases dramatically with age, and morbidity associated with

neurological disorders is expected to rise dramatically in the coming

years in lockstep with the aging of the population. Evidence that

neurogenesis persists beyond the embryonic and early developmental

periods has led to a number of programs in academia and the

commercial sector that seek to stimulate the differentiation and

growth of adult neural stem cells.

A number of small companies are focusing on the development of

methods and tools to enhance the regenerative responses of axons

following different kinds of acute insults or chronic damage

resulting from neurological conditions. Advances in neurogenesis and

nerve regeneration are being chaperoned by a number of enabling

technologies such as functional mapping, which is already being used

in a number of clinical settings, and enhanced diagnostic imaging.

These developments will accelerate the pace of clinical successes in

a segment with significant market potential.

These findings are contained in a new and comprehensive report.

Neurogenesis and Nerve Regeneration contains detailed and insightful

analysis of programs, participants and prospects in this evolving

sector.

About Greystone

Greystone Associates is a medical and healthcare technology

consulting firm providing services in strategic planning, venture

development, product commercialization, and technology and market

assessment.

http://www.greystoneassociates.org